Loading…
Steady-State Modulation of Voltage-Gated K.sup.+ Channels in Rat Arterial Smooth Muscle by Cyclic AMP-Dependent Protein Kinase and Protein Phosphatase 2B
Voltage-gated potassium channels (K.sub.v) are important regulators of membrane potential in vascular smooth muscle cells, which is integral to controlling intracellular Ca2+ concentration and regulating vascular tone. Previous work indicates that K.sub.v channels can be modulated by receptor-driven...
Saved in:
Published in: | PloS one 2015-03, Vol.10 (3) |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Voltage-gated potassium channels (K.sub.v) are important regulators of membrane potential in vascular smooth muscle cells, which is integral to controlling intracellular Ca2+ concentration and regulating vascular tone. Previous work indicates that K.sub.v channels can be modulated by receptor-driven alterations of cyclic AMP-dependent protein kinase (PKA) activity. Here, we demonstrate that K.sub.v channel activity is maintained by tonic activity of PKA. Whole-cell recording was used to assess the effect of manipulating PKA signalling on K.sub.v and ATP-dependent K+ channels of rat mesenteric artery smooth muscle cells. Application of PKA inhibitors, KT5720 or H89, caused a significant inhibition of K.sub.v currents. Tonic PKA-mediated activation of K.sub.v appears maximal as application of isoprenaline (a [beta]-adrenoceptor agonist) or dibutyryl-cAMP failed to enhance K.sub.v currents. We also show that this modulation of K.sub.v by PKA can be reversed by protein phosphatase 2B/calcineurin (PP2B). PKA-dependent inhibition of K.sub.v by KT5720 can be abrogated by pre-treatment with the PP2B inhibitor cyclosporin A, or inclusion of a PP2B auto-inhibitory peptide in the pipette solution. Finally, we demonstrate that tonic PKA-mediated modulation of K.sub.v requires intact caveolae. Pre-treatment of the cells with methyl-[beta]-cyclodextrin to deplete cellular cholesterol, or adding caveolin-scaffolding domain peptide to the pipette solution to disrupt caveolae-dependent signalling each attenuated PKA-mediated modulation of the K.sub.v current. These findings highlight a novel, caveolae-dependent, tonic modulatory role of PKA on K.sub.v channels providing new insight into mechanisms and the potential for pharmacological manipulation of vascular tone. |
---|---|
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0121285 |